Details of the Drug

General Information of Drug (ID: DMSEGKC)

• Drug Name: JNJ-79635322
• Synonyms: JNJ-5322

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1	[1]

• Cross-matching ID: TTD ID: DRFS19

References

• [1] ClinicalTrials.gov (NCT05652335) Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis. U.S.National Institutes of Health.